The platform, Eva, is compatible with all commercially implanted Evoke spinal cord stimulator systems, according to a Jan. 23 news release. Eva senses, measures and adjusts stimulation based on each patient’s unique response.
“EVA has the potential to usher in new benefits for clinicians and staff with greater ease of use, faster and more consistent programming, and monitoring physiological data to adjust settings to an optimal therapeutic dose,” Timothy Deer, MD, president and CEO of The Spine & Nerve Center of the Virginias in Charleston, W.Va, said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
